His research activity focuses on the biomanufacture of advanced therapeutics including cell, gene and tissue-based therapy. Dr Rafiq’s currently leads a research portfolio > £2M focused on translational science, specifically process control strategies to drive product consistency. He is a Chartered Engineering (CEng), a Chartered Scientist (CSci) and is currently pursuing an MBA.